Drug Pipeline

STRIDE Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
3
Recruiting
3
Top Sponsors
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-05-26 NCT07607769 MONTEROSA - Italian Multicenter Observational Study to Evaluate Time to Clinical Hepatic… Recruiting
Active Studies by Phase
Phase 2
2
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07175441 Evaluation of RBS2418 in Combination With Tremelimumab Plus Durvalumab in Participants… Advanced Unresectable Hepatocellular Carcinoma Recruiting
NCT06880523 STRIDE (Durvalumab + Tremelimumab) With Lenvatinib vs STRIDE Alone in Unresectable… Hepatocellular Carcinoma Recruiting
Not specified
NCT07607769 MONTEROSA - Italian Multicenter Observational Study to Evaluate Time to Clinical Hepatic… Hepatocellular Carcinoma Recruiting
Sponsors Running STRIDE Trials
Canadian Cancer Trials Group (1) Riboscience, LLC. (1) AstraZeneca (1)
Disease Areas
Liver Cancer (3)
Get alerts when STRIDE trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free